Advertisement
Screener

MeiraGTx Holdings plc (MGTX) Other

MeiraGTx Holdings plc Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-03-30: Form 10-K; Item Stock registered under Section 12(b); As filed Ordinary Shares, $0.00003881 par value per share · MGTX · The Nasdaq Global Select Market.
  • 2025-03-13: Form 10-K; Item Stock registered under Section 12(b); As filed Ordinary Shares, $0.00003881 par value per share · MGTX · The Nasdaq Global Select Market.
  • 2024-03-15: Form 10-K; Item Stock registered under Section 12(b); As filed Ordinary Shares, $0.00003881 par value per share · MGTX · The Nasdaq Global Select Market.
  • 2023-11-14: Form 10-Q; Item Emerging growth company; As filed Yes.
FiledFormItemAs filed
2026-03-3010-KStock registered under Section 12(b)Ordinary Shares, $0.00003881 par value per share · MGTX · The Nasdaq Global Select Market
2025-03-1310-KStock registered under Section 12(b)Ordinary Shares, $0.00003881 par value per share · MGTX · The Nasdaq Global Select Market
2024-03-1510-KStock registered under Section 12(b)Ordinary Shares, $0.00003881 par value per share · MGTX · The Nasdaq Global Select Market
2023-11-1410-QEmerging growth companyYes
2023-08-1010-QEmerging growth companyYes
2023-05-1110-QEmerging growth companyYes
2023-03-1410-KStock registered under Section 12(b)Ordinary Shares, $0.00003881 par value per share · MGTX · The Nasdaq Global Select Market
2023-03-1410-KEmerging growth companyYes
2022-11-1010-QEmerging growth companyYes
2022-08-1110-QEmerging growth companyYes
2022-05-1210-QEmerging growth companyYes
2022-03-1010-KStock registered under Section 12(b)Ordinary Shares, $0.00003881 par value per share · MGTX · The Nasdaq Global Select Market
2022-03-1010-KEmerging growth companyYes
2021-11-1010-QEmerging growth companyYes
2021-08-1110-QEmerging growth companyYes
2021-05-1110-QEmerging growth companyYes
2021-03-1110-KStock registered under Section 12(b)Ordinary Shares, $0.00003881 par value per share · MGTX · The Nasdaq Global Select Market
2021-03-1110-KEmerging growth companyYes
2020-11-0510-QEmerging growth companyYes
2020-08-0610-QStock registered under Section 12(b)Ordinary Shares · MGTX · The Nasdaq
2020-08-0610-QEmerging growth companyYes
2020-05-0710-QStock registered under Section 12(b)Ordinary Shares · MGTX
2020-05-0710-QEmerging growth companyYes
2020-03-1110-KEmerging growth companyYes
2019-11-0710-QStock registered under Section 12(b)Ordinary Shares · MGTX · NASDAQ
2019-11-0710-QEmerging growth companyYes
2019-08-0710-QStock registered under Section 12(b)Ordinary Shares · MGTX · NASDAQ
2019-08-0710-QEmerging growth companyYes
2019-05-1410-QEmerging growth companyYes
2019-03-2610-KEmerging growth companyYes
2018-11-0810-QSmaller reporting companyNo
2018-11-0810-QEmerging growth companyYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Monte Rosa Therapeutics, Inc. (GLUE)United States$1.002B-12.81
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Replimune Group, Inc. (REPL)United States$1.186B-3.13
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10